100 related articles for article (PubMed ID: 32727562)
21. A risk-associated Active transcriptome phenotype expressed by histologically normal human breast tissue and linked to a pro-tumorigenic adipocyte population.
Kang T; Yau C; Wong CK; Sanborn JZ; Newton Y; Vaske C; Benz SC; Krings G; Camarda R; Henry JE; Stuart J; Powell M; Benz CC
Breast Cancer Res; 2020 Jul; 22(1):81. PubMed ID: 32736587
[TBL] [Abstract][Full Text] [Related]
22. Breast cancer patient-derived whole-tumor cell culture model for efficient drug profiling and treatment response prediction.
Chen X; Sifakis EG; Robertson S; Neo SY; Jun SH; Tong L; Hui Min AT; Lövrot J; Hellgren R; Margolin S; Bergh J; Foukakis T; Lagergren J; Lundqvist A; Ma R; Hartman J
Proc Natl Acad Sci U S A; 2023 Jan; 120(1):e2209856120. PubMed ID: 36574653
[TBL] [Abstract][Full Text] [Related]
23. Decreased DNA Damage and Improved p53 Specificity of RITA Analogs.
Zhan Y; Zhou X; Peuget S; Singh M; Peyser BD; Fan Z; Selivanova G
Mol Cancer Ther; 2022 Oct; 21(10):1524-1534. PubMed ID: 35877475
[TBL] [Abstract][Full Text] [Related]
24. Cross-Resistance Among Sequential Cancer Therapeutics: An Emerging Issue.
Loria R; Vici P; Di Lisa FS; Soddu S; Maugeri-Saccà M; Bon G
Front Oncol; 2022; 12():877380. PubMed ID: 35814399
[TBL] [Abstract][Full Text] [Related]
25. DNA methylation changes in response to neoadjuvant chemotherapy are associated with breast cancer survival.
Pedersen CA; Cao MD; Fleischer T; Rye MB; Knappskog S; Eikesdal HP; Lønning PE; Tost J; Kristensen VN; Tessem MB; Giskeødegård GF; Bathen TF
Breast Cancer Res; 2022 Jun; 24(1):43. PubMed ID: 35751095
[TBL] [Abstract][Full Text] [Related]
26. The Employment of Genera
Maiuolo J; Musolino V; Gliozzi M; Carresi C; Oppedisano F; Nucera S; Scarano F; Scicchitano M; Guarnieri L; Bosco F; Macrì R; Ruga S; Cardamone A; Coppoletta AR; Ilari S; Mollace A; Muscoli C; Cognetti F; Mollace V
Nutrients; 2022 Apr; 14(8):. PubMed ID: 35458136
[TBL] [Abstract][Full Text] [Related]
27. Factors Promoting Tamoxifen Resistance in Breast Cancer via Stimulating Breast Cancer Stem Cell Expansion.
Ojo D; Wei F; Liu Y; Wang E; Zhang H; Lin X; Wong N; Bane A; Tang D
Curr Med Chem; 2015; 22(19):2360-74. PubMed ID: 25882671
[TBL] [Abstract][Full Text] [Related]
28. The role of mitochondrial/metabolic axis in development of tamoxifen resistance in breast cancer.
Azzam HN; El-Derany MO; Wahdan SA; Faheim RM; Helal GK; El-Demerdash E
Hum Cell; 2023 Nov; 36(6):1877-1886. PubMed ID: 37646973
[TBL] [Abstract][Full Text] [Related]
29. Identification and targeting of selective vulnerability rendered by tamoxifen resistance.
Singh M; Zhou X; Chen X; Santos GS; Peuget S; Cheng Q; Rihani A; Arnér ESJ; Hartman J; Selivanova G
Breast Cancer Res; 2020 Jul; 22(1):80. PubMed ID: 32727562
[TBL] [Abstract][Full Text] [Related]
30. Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer.
Mishra RR; Belder N; Ansari SA; Kayhan M; Bal H; Raza U; Ersan PG; Tokat ÜM; Eyüpoğlu E; Saatci Ö; Jandaghi P; Wiemann S; Üner A; Cekic C; Riazalhosseini Y; Şahin Ö
Clin Cancer Res; 2018 Apr; 24(8):1987-2001. PubMed ID: 29386221
[No Abstract] [Full Text] [Related]
31. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
[TBL] [Abstract][Full Text] [Related]
32. Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer.
Larsen SL; Yde CW; Laenkholm AV; Rasmussen BB; Duun-Henriksen AK; Bak M; Lykkesfeldt AE; Kirkegaard T
BMC Cancer; 2015 Apr; 15():239. PubMed ID: 25885472
[TBL] [Abstract][Full Text] [Related]
33. A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer.
Sambi M; Samuel V; Qorri B; Haq S; Burov SV; Markvicheva E; Harless W; Szewczuk MR
Drug Des Devel Ther; 2020; 14():1995-2019. PubMed ID: 32546966
[TBL] [Abstract][Full Text] [Related]
34. Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients.
Wegman P; Vainikka L; Stål O; Nordenskjöld B; Skoog L; Rutqvist LE; Wingren S
Breast Cancer Res; 2005; 7(3):R284-90. PubMed ID: 15987423
[TBL] [Abstract][Full Text] [Related]
35. Thermal Proteome Profiling Identifies Oxidative-Dependent Inhibition of the Transcription of Major Oncogenes as a New Therapeutic Mechanism for Select Anticancer Compounds.
Peuget S; Zhu J; Sanz G; Singh M; Gaetani M; Chen X; Shi Y; Saei AA; Visnes T; Lindström MS; Rihani A; Moyano-Galceran L; Carlson JW; Hjerpe E; Joneborg U; Lehti K; Hartman J; Helleday T; Zubarev R; Selivanova G
Cancer Res; 2020 Apr; 80(7):1538-1550. PubMed ID: 32019870
[TBL] [Abstract][Full Text] [Related]
36.
Lei JT; Gou X; Seker S; Ellis MJ
J Cancer Metastasis Treat; 2019; 5():. PubMed ID: 31106278
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
